tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sagimet Biosciences: Promising Advancements in FASN Inhibitor Platform and Strategic Growth Initiatives Justify Buy Rating
PremiumRatingsSagimet Biosciences: Promising Advancements in FASN Inhibitor Platform and Strategic Growth Initiatives Justify Buy Rating
2M ago
Sagimet Biosciences Reports Progress in Acne and MASH Trials
Premium
Company Announcements
Sagimet Biosciences Reports Progress in Acne and MASH Trials
2M ago
Sagimet Biosciences Enters New Sales Agreement with Leerink
Premium
Company Announcements
Sagimet Biosciences Enters New Sales Agreement with Leerink
2M ago
Sagimet Biosciences initiated with an Outperform at Wedbush
PremiumThe FlySagimet Biosciences initiated with an Outperform at Wedbush
2M ago
Eli Lilly downgraded, Lyft upgraded: Wall Street’s top analyst calls
Premium
The Fly
Eli Lilly downgraded, Lyft upgraded: Wall Street’s top analyst calls
2M ago
Promising Prospects for Sagimet Biosciences: Buy Rating Backed by Innovative FASN Inhibitor Platform and Clinical Advancements
Premium
Ratings
Promising Prospects for Sagimet Biosciences: Buy Rating Backed by Innovative FASN Inhibitor Platform and Clinical Advancements
2M ago
3 Best Stocks to Buy Now, 6/23/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 6/23/2025, According to Top Analysts
3M ago
Buy Rating for Sagimet Biosciences Driven by Promising Clinical Data and Market Potential of Denifanstat
Premium
Ratings
Buy Rating for Sagimet Biosciences Driven by Promising Clinical Data and Market Potential of Denifanstat
3M ago
Sagimet Biosciences Elects New Directors at Annual Meeting
Premium
Company Announcements
Sagimet Biosciences Elects New Directors at Annual Meeting
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100